Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

More documents

Recommendations

Info

06 GLOBAL DRUG FACILITY Operations GDF is a team within the Stop TB Partnership Secretariat. It is totally funded by donors and is responsible for procurement of anti-TB medicines, relevant diagnostics and commodities for grant applications, review / administration and technical assistance. Certain procurement services are outsourced to third party procurement agents, identified following competitive bidding. The procurement agent is guided and monitored by the GDF team and is responsible for many aspects of procurement, including competitive bidding, contract implementation, purchase order issuance, logistics, contract performance management / evaluation, and communication with clients. Technical assistance is provided by specialists contracted to conduct annual monitoring missions and report back on their findings, as well as workshops for capacity building. © WHO / Evelyn Hockstein
07 ANNUAL REPORT 2011 Commodity expenditure and funding sources GDF’s major donors since 2001 have been the United States Agency for International Development (USAID), UNITAID, the Canadian International Development Agency (CIDA) and the United Kingdom Department for International Development (DFID). These four donors continued to support GDF in 2011. Donor funds were used primarily to procure drugs and diagnostics for GDF grant countries and to provide technical assistance. Since GDF does not currently generate any income through a handling fee on the Direct Procurement Services orders it processes, donor funds were also used to cover GDF’s operating costs. The DFID funding, as per an agreement with GDF, was dedicated exclusively to procurement of FLDs for India. The DFID grant ended on 31 December 2011. GeneXpert $ 6 363 807 New Diagnostics $ 6 405 667 FLD $ 56 511 227 SLD $ 85 291 452 Note: The figure for GeneXpert includes cartridges at $ 4 244 610 and machines at $ 2 119 197 Figure 1 Expenditure breakdown 2011
Page 1 and 2: GLOBAL DRUG FACILITY ANNUAL REPORT
Page 3 and 4: Contents 02 | About the Global Drug
Page 5 and 6: 03 ANNUAL REPORT 2011 Message from
Page 7: 05 ANNUAL REPORT 2011 GDF was estab
Page 11 and 12: 9 ANNUAL REPORT 2011 2010 GDF Grant
Page 13 and 14: 11 ANNUAL REPORT 2011 Historical an
Page 15 and 16: 13 ANNUAL REPORT 2011 80 70 60 Proc
Page 17 and 18: 15 ANNUAL REPORT 2011 2010 2011 Fre
Page 19 and 20: 17 ANNUAL REPORT 2011 There were ot
Page 21 and 22: 19 ANNUAL REPORT 2011 Diagnostics I
Page 23 and 24: 21 ANNUAL REPORT 2011 First-line dr
Page 25 and 26: 23 ANNUAL REPORT 2011 MDR-TB throug
Page 27 and 28: 25 ANNUAL REPORT 2011 Stockpile In
Page 29 and 30: 27 ANNUAL REPORT 2011 Key performan
Page 31 and 32: 29 ANNUAL REPORT 2011 Review • An
Page 33 and 34: 31 ANNUAL REPORT 2011 Monitoring mi
Page 35 and 36: 33 ANNUAL REPORT 2011 Annex 2 Patie
Page 37 and 38: 35 ANNUAL REPORT 2011 Country 2011
Page 39 and 40: 37 ANNUAL REPORT 2011 Country Suppl
Page 41 and 42: 39 ANNUAL REPORT 2011 WHO Region Co
Page 43 and 44: 41 ANNUAL REPORT 2011 Annex 5 GeneX
Page 45 and 46: 43 ANNUAL REPORT 2011 Countries rev
Page 48: Stop TB Partnership www.stoptb.org

Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?